Northern Star Investment Corp. II: Nasdaq/NYSE listing notice — Northern Star Investment Corp. II receives NYSE American notice for late Q1 10-Q; six-month cure period

Northern Star Investment Corp. II

Received NYSE American notice on May 23, 2023, for failing to timely file Form 10-Q for quarter ended March 31, 2023, due May 22.
Company has six months from original due date (May 22) to file the Quarterly Report and regain compliance.
Company cites lack of full-time accounting and administrative staff as reason for delay.
No immediate effect on listing of securities (NSTB, NSTB.U, NSTB WS) on NYSE American.
Company intends to file the Quarterly Report as soon as practicable within the cure period.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Northern Star Investment Corp. II received a nyse_american noncompliance notice notice regarding late filing.

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing

Exact text from the filing

May 23, 2023, Northern Star Investment Corp. II (the “ Company ”) received a written notice (the “ Notice ”) from New York Stock Exchange Regulation, Inc. indicating that the Company that it was not in compliance with NYSE American’s continued listing standards because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter March 31, 2023 (the “ Quarterly Report ”), which was due on May 22, 2023. The Company has a period of six months from the original due date of the Quarterly Report to file such report. The Company can regain compliance with the NYSE American’s cont

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-042763

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.